Revive Therapeutics Ltd. rose 33.3% on Friday, October 30, 2026, on 212,393 shares. No headline about RVV came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Revive Therapeutics Ltd. (RVV:CSE) closed at $0.020 on November 2, 2026, unchanged on the day. The stock trades 75.0% below its 52-week high of $0.080 and 300.0% above its 52-week low of $0.005. Over the past year, it gained 33.3%. Revive Therapeutics Ltd. is part of the Life Sciences sector.
In 252 trading sessions since October 30, 2025, RVV closed higher on 47 days (19%). Its best day was March 11, 2026 (+100.00%) and its worst was December 8, 2025 (-60.00%). The stock moved 10% or more in a single session 96 times. It opened at least 5% above the previous day's high 31 times.
Revive Therapeutics Ltd is a Canada based company primarily focused on the manufacturing of drugs for medical needs. The company researches develop and commercialize novel treatments for serious and unmet medical needs in the medical cannabis and cannabinoid pharmaceuticals markets. The products of the company include REV-100 Topical hydrogel cannabidiol, REV-200 Cannabidiol, REV-004, REV-002, and others.
Find more stocks like RVV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.